Smart Insulin Pens Market Size, Share, and Trends 2024 to 2034

The global smart insulin pens market size is estimated at USD 183.25 million in 2025 and is predicted to reach around USD 676.01 million by 2034, accelerating at a CAGR of 15.65% from 2025 to 2034. The Europe smart insulin pens market size surpassed USD 76.97 million in 2025 and is expanding at a CAGR of 15.78% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : January 2025
  • Report Code : 1897
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. End User Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Smart Insulin Pens Market 

5.1. COVID-19 Landscape: Smart Insulin Pens Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Smart Insulin Pens Market, By Type

8.1. Smart Insulin Pens Market, by Type

8.1.1. First Generation Pens

8.1.1.1. Market Revenue and Forecast

8.1.2. Second Generation Pens

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Smart Insulin Pens Market, By Usability

9.1. Smart Insulin Pens Market, by Usability

9.1.1. Prefilled

9.1.1.1. Market Revenue and Forecast

9.1.2. Reusable

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Smart Insulin Pens Market, By Product

10.1. Smart Insulin Pens Market, by Product

10.1.1. Smart Insulin Pen

10.1.1.1. Market Revenue and Forecast

10.1.2. Adaptors for Conventional Pen

10.1.2.1. Market Revenue and Forecast

Chapter 11. Global Smart Insulin Pens Market, By Connectivity Type

11.1. Smart Insulin Pens Market, by Connectivity Type

11.1.1. Bluetooth

11.1.1.1. Market Revenue and Forecast

11.1.2. USB

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Smart Insulin Pens Market, By Indication

12.1. Smart Insulin Pens Market, by Indication

12.1.1. Type 1 Diabetes

12.1.1.1. Market Revenue and Forecast

12.1.2. Type 2 Diabetes

12.1.2.1. Market Revenue and Forecast

Chapter 13. Global Smart Insulin Pens Market, By End User

13.1. Smart Insulin Pens Market, by End User

13.1.1. Hospitals and Clinics

13.1.1.1. Market Revenue and Forecast

13.1.2. Ambulatory Surgical Centers

13.1.2.1. Market Revenue and Forecast

13.1.3. Home Care Settings

13.1.3.1. Market Revenue and Forecast

Chapter 14. Global Smart Insulin Pens Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Type

14.1.2. Market Revenue and Forecast, by Usability

14.1.3. Market Revenue and Forecast, by Product

14.1.4. Market Revenue and Forecast, by Connectivity Type

14.1.5. Market Revenue and Forecast, by Indication

14.1.6. Market Revenue and Forecast, by End User

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Type

14.1.7.2. Market Revenue and Forecast, by Usability

14.1.7.3. Market Revenue and Forecast, by Product

14.1.7.4. Market Revenue and Forecast, by Connectivity Type

14.1.8. Market Revenue and Forecast, by Indication

14.1.8.1. Market Revenue and Forecast, by End User  

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Type

14.1.9.2. Market Revenue and Forecast, by Usability

14.1.9.3. Market Revenue and Forecast, by Product

14.1.9.4. Market Revenue and Forecast, by Connectivity Type

14.1.10. Market Revenue and Forecast, by Indication

14.1.11. Market Revenue and Forecast, by End User

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Type

14.2.2. Market Revenue and Forecast, by Usability

14.2.3. Market Revenue and Forecast, by Product

14.2.4. Market Revenue and Forecast, by Connectivity Type  

14.2.5. Market Revenue and Forecast, by Indication

14.2.6. Market Revenue and Forecast, by End User

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Type

14.2.8.2. Market Revenue and Forecast, by Usability

14.2.8.3. Market Revenue and Forecast, by Product

14.2.9. Market Revenue and Forecast, by Connectivity Type  

14.2.10. Market Revenue and Forecast, by Indication

14.2.10.1. Market Revenue and Forecast, by End User  

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Type

14.2.11.2. Market Revenue and Forecast, by Usability

14.2.11.3. Market Revenue and Forecast, by Product

14.2.12. Market Revenue and Forecast, by Connectivity Type

14.2.13. Market Revenue and Forecast, by Indication

14.2.14. Market Revenue and Forecast, by End User

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Type

14.2.15.2. Market Revenue and Forecast, by Usability

14.2.15.3. Market Revenue and Forecast, by Product

14.2.15.4. Market Revenue and Forecast, by Connectivity Type

14.2.16. Market Revenue and Forecast, by Indication

14.2.16.1. Market Revenue and Forecast, by End User

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Type

14.2.17.2. Market Revenue and Forecast, by Usability

14.2.17.3. Market Revenue and Forecast, by Product

14.2.17.4. Market Revenue and Forecast, by Connectivity Type

14.2.18. Market Revenue and Forecast, by Indication

14.2.18.1. Market Revenue and Forecast, by End User

14.3. APAC

14.3.1. Market Revenue and Forecast, by Type

14.3.2. Market Revenue and Forecast, by Usability

14.3.3. Market Revenue and Forecast, by Product

14.3.4. Market Revenue and Forecast, by Connectivity Type

14.3.5. Market Revenue and Forecast, by Indication

14.3.6. Market Revenue and Forecast, by End User

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Type

14.3.7.2. Market Revenue and Forecast, by Usability

14.3.7.3. Market Revenue and Forecast, by Product

14.3.7.4. Market Revenue and Forecast, by Connectivity Type

14.3.8. Market Revenue and Forecast, by Indication

14.3.9. Market Revenue and Forecast, by End User

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Type

14.3.10.2. Market Revenue and Forecast, by Usability

14.3.10.3. Market Revenue and Forecast, by Product

14.3.10.4. Market Revenue and Forecast, by Connectivity Type

14.3.11. Market Revenue and Forecast, by Indication

14.3.11.1. Market Revenue and Forecast, by End User

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Type

14.3.12.2. Market Revenue and Forecast, by Usability

14.3.12.3. Market Revenue and Forecast, by Product

14.3.12.4. Market Revenue and Forecast, by Connectivity Type

14.3.12.5. Market Revenue and Forecast, by Indication

14.3.12.6. Market Revenue and Forecast, by End User

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Type

14.3.13.2. Market Revenue and Forecast, by Usability

14.3.13.3. Market Revenue and Forecast, by Product

14.3.13.4. Market Revenue and Forecast, by Connectivity Type

14.3.13.5. Market Revenue and Forecast, by Indication

14.3.13.6. Market Revenue and Forecast, by End User

14.4. MEA

14.4.1. Market Revenue and Forecast, by Type

14.4.2. Market Revenue and Forecast, by Usability

14.4.3. Market Revenue and Forecast, by Product

14.4.4. Market Revenue and Forecast, by Connectivity Type

14.4.5. Market Revenue and Forecast, by Indication

14.4.6. Market Revenue and Forecast, by End User

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Type

14.4.7.2. Market Revenue and Forecast, by Usability

14.4.7.3. Market Revenue and Forecast, by Product

14.4.7.4. Market Revenue and Forecast, by Connectivity Type

14.4.8. Market Revenue and Forecast, by Indication

14.4.9. Market Revenue and Forecast, by End User

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Type

14.4.10.2. Market Revenue and Forecast, by Usability

14.4.10.3. Market Revenue and Forecast, by Product

14.4.10.4. Market Revenue and Forecast, by Connectivity Type

14.4.11. Market Revenue and Forecast, by Indication

14.4.12. Market Revenue and Forecast, by End User

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Type

14.4.13.2. Market Revenue and Forecast, by Usability

14.4.13.3. Market Revenue and Forecast, by Product

14.4.13.4. Market Revenue and Forecast, by Connectivity Type

14.4.13.5. Market Revenue and Forecast, by Indication

14.4.13.6. Market Revenue and Forecast, by End User

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Type

14.4.14.2. Market Revenue and Forecast, by Usability

14.4.14.3. Market Revenue and Forecast, by Product

14.4.14.4. Market Revenue and Forecast, by Connectivity Type

14.4.14.5. Market Revenue and Forecast, by Indication

14.4.14.6. Market Revenue and Forecast, by End User

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Type

14.5.2. Market Revenue and Forecast, by Usability

14.5.3. Market Revenue and Forecast, by Product

14.5.4. Market Revenue and Forecast, by Connectivity Type

14.5.5. Market Revenue and Forecast, by Indication

14.5.6. Market Revenue and Forecast, by End User

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Type

14.5.7.2. Market Revenue and Forecast, by Usability

14.5.7.3. Market Revenue and Forecast, by Product

14.5.7.4. Market Revenue and Forecast, by Connectivity Type

14.5.8. Market Revenue and Forecast, by Indication

14.5.8.1. Market Revenue and Forecast, by End User

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Type

14.5.9.2. Market Revenue and Forecast, by Usability

14.5.9.3. Market Revenue and Forecast, by Product

14.5.9.4. Market Revenue and Forecast, by Connectivity Type

14.5.9.5. Market Revenue and Forecast, by Indication

14.5.9.6. Market Revenue and Forecast, by End User

Chapter 15. Company Profiles

15.1. Emperra GmbH

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Bigfoot Biomedical

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Digital Medics Pty Ltd.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Jiangsu Deflu Medical Device Co.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Medtronic plc

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Eli Lilly and Company

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. Novo Nordisk

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Pendiq

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. Sanofi

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Berlin-Chemie

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global smart insulin pens market size was accounted at USD 157.97 million in 2024 and it is expected to reach around USD 676.01 million by 2034.

The global smart insulin pens market is poised to grow at a CAGR of 15.65% from 2025 to 2034.

The major players operating in the smart insulin pens market are Emperra GmbH, Bigfoot Biomedical, Digital Medics Pty Ltd., Jiangsu Deflu Medical Device Co., Medtronic plc, Eli Lilly and Company, Novo Nordisk, Pendiq, Sanofi, Berlin-Chemie

The smart insulin pen devices help to record the blood sugar levels of the individual and directly seeded into the system to be recorded in the health profile of the person

Europe region will lead the global smart insulin pens market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client